High-Dose Interleukin-2 Followed by Temozolomide Results in Response Rates of High Quality in Metastatic Melanoma

被引：0
|
作者：
Fateh, Salman [1 ]
Schell, Todd
Gingrich, Rebecca [1 ]
Neves, Rogerio [2 ]
Drabick, Joseph [1 ]
机构：
[1] Penn State Hershey Med Ctr, Dept Hematol & Oncol, Hershey, PA USA
[2] Penn State Hershey Med Ctr, Dept Plast Surg, Hershey, PA USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2009年 / 32卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：956 / 956
页数：1
相关论文
共 50 条
  • [21] Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide
    Soni, S
    Lee, DS
    DiVito, J
    Bui, AH
    DeRaffele, G
    Radel, E
    Kaufman, HL
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (06) : 488 - 491
  • [22] The application of high-dose interleukin-2 for metastatic renal cell carcinoma
    McDermott, David F.
    MEDICAL ONCOLOGY, 2009, 26 : 13 - 17
  • [23] Metastasectomy following incomplete response to high-dose interleukin-2
    Hughes, Tasha
    Broucek, Joseph
    Iodice, Gail
    Bommareddy, Praveen K.
    Basu, Sanjib
    Kaufman, Howard L.
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (04) : 572 - 578
  • [24] High-dose interleukin-2 in metastatic renal cell carcinoma - Reply
    McDermott, DF
    Atkins, MB
    Regan, MM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6798 - 6799
  • [25] The application of high-dose interleukin-2 for metastatic renal cell carcinoma
    David F. McDermott
    Medical Oncology, 2009, 26 : 13 - 17
  • [26] Dystonia in a Patient with Melanoma Metastatic to the Brain Treated with High-Dose Interleukin-2, Radiation Therapy, and Levetiracetam
    Sreenivasan, Varun
    Dudek, Arkadiusz Z.
    CASE REPORTS IN ONCOLOGY, 2013, 6 (01): : 78 - 83
  • [27] Successful treatment of cutaneous metastatic melanoma with high-dose intralesional interleukin-2 treatment combined with cryosurgery
    Martinez-Lopez, Antonio
    Manuel Almazan-Fernandez, Francisco
    Perez-Lopez, Israel
    Aguayo-Carreras, Paula
    Salvador-Rodriguez, Luis
    Cuenca-Barrales, Carlos
    Arias-Santiago, Salvador
    DERMATOLOGIC THERAPY, 2018, 31 (04)
  • [28] HIGH-DOSE INTERLEUKIN-2 IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA AND MELANOMA: A CONTEMPORARY LOUISIANA EXPERIENCE
    Kwan, Nathan
    Patel, Charmi
    Miletello, Gerald P.
    Brantley, Paula Rhode
    ANTICANCER RESEARCH, 2015, 35 (12) : 6702 - 6702
  • [29] Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
    Bulgarelli, Jenny
    Piccinini, Claudia
    Petracci, Elisabetta
    Pancisi, Elena
    Granato, Anna Maria
    de Rosa, Francesco
    Guidoboni, Massimo
    Petrini, Massimiliano
    Ancarani, Valentina
    Foschi, Giovanni
    Romeo, Antonino
    Tontini, Luca
    De Giorgi, Ugo
    Lolli, Cristian
    Gentili, Giorgia
    Valmorri, Linda
    Rossi, Alice
    Ferroni, Fabio
    Casadei, Carla
    Cortesi, Pietro
    Crudi, Laura
    Ridolfi, Laura
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [30] A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
    Buchbinder, Elizabeth I.
    Gunturi, Anasuya
    Perritt, Jessica
    Dutcher, Janice
    Aung, Sandra
    Kaufman, Howard L.
    Ernstoff, Marc S.
    Miletello, Girald P.
    Curti, Brendan D.
    Daniels, Gregory A.
    Patel, Sapna P.
    Kirkwood, John M.
    Hallmeyer, Sigrun
    Clark, Joseph I.
    Gonzalez, Rene
    Richart, John M.
    Lutzky, Joe
    Morse, Michael A.
    Sullivan, Ryan J.
    McDermott, David F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
12345